Biochemical indices of blood in women suffering from anovulatory infertility during xenical treatment

Summary. Obesity is a common problem among women of childbearing age. It is known that obesity negatively affects various types of metabolism, many organs and organ systems, and in particular, a woman's fertility. Thus, obese women of childbearing age may experience menstrual irregularities, endometrial pathology, and infertility. The aim of the study – to determine changes in serum biochemical parameters in women with Xenical-induced anovulatory infertility. Materials and Methods. We surveyed 82 obese women who complained of no pregnancy for 2 years or more in the presence of regular sex without the use of contraceptives. Patients were divided into two equal groups: group 1 included 42 women, group 2 – 40 women. Comprehensive treatment of obesity in patients of group 1 was supplemented with the drug Xenical. A laboratory study was performed at the beginning of the experiment, after 3 and 6 months: blood lipid spectrum, ALT, AST, CRP, TSH, adiponectin, insulin, and OGTT. Results. Follow-up of patients in the first stage of the study was carried out for 6 months. Six months later, body weight in patients of group 1 decreased on average to (80.5±0.9) kg, in patients of group 2 – to (94.4±1.1) kg.  In group 1, 36 patients became pregnant, in group 2 – 19.  During the screening phase of the laboratory study in the experimental and control groups, elevated levels of cholesterol, LDL cholesterol, triglycerides, and decreased levels of HDL cholesterol and adiponectin. After 6 months, differences in the dynamics of lipid metabolism were recorded. Thus, cholesterol in the main group decreased by -0.35 [-0.75; 0.05] mol/l, and the control only -0.05 [-0.15; 0.25] mol/l (p = 0.027). There was a statistically significant difference between the groups in the reduction of atherogenic LDL. In six months of the study, all women who took Xenical showed normalization of cholesterol levels, decreased CRP, and increased adiponectin levels. Conclusions. Xenical is effective in the fight against obesity, improves laboratory blood tests, has a particularly positive effect on lipid metabolism, which resulted in the possibility of pregnancy in most patients who took this drug

Xenical, obesity, anovulatory infertility

https://doi.org/10.11603/bmbr.2706-6290.2022.1.12902

[1] Broughton D, Moley K. Obesity and female infertility: potential  mediators  of  obesity's  impact.  Fertil  Steril. 2017;107(4): 840-47. DOI: 10.1016/j.fertnstert.2017.01.017.

[2] Persson M, Cnattingius S, Villamor E et al. Risk of major  congenital  malformations  in  relation  to  maternal overweight and obesity severity: cohort study of 1.2 million singletons. BMJ. 2017:j2563. DOI: 10.1136/bmj.j2563.

[3] Savastano S, Di Somma C, Barrea L, Colao A. The complex relationship between obesity and the somatropic axis:  The  long  and  winding  road.  Growth  Hormone &  IGF  Research.  2014;24(6):  221-6.  DOI:  10.1016/j.ghir.2014.09.002.

[4] Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity  as  disruptor  of  the  female  fertility.  Reproductive Biology  and  Endocrinology.  2018;16(1).  DOI:  10.1186/s12958-018-0336-z.

[5] Gambineri A,  Laudisio  D,  Marocco  C,  Radellini  S, Colao  A,  Savastano  S.  Female  infertility:  which  role  for obesity?. Int J Obes Suppl. 2019;9(1): 65-72. DOI: 10.1038/s41367-019-0009-1.

[6] Machtinger  R,  Combelles  C,  Missmer  S,  Correia K,  Fox  J,  Racowsky  C.  The  association  between severe  obesity  and  characteristics  of  failed  fertilized oocytes.  Human  Reproduction.  2012;27(11):  3198-207. DOI: 10.1093/humrep/des308.

[7] Broughton D, Jungheim E. A Focused Look at Obesity and the Preimplantation Trophoblast. Semin Reprod Med. 2015;34(01): 005-010. DOI: 10.1055/s-0035-1570032.

[8] Sim  K,  Dezarnaulds  G,  Denyer  G,  Skilton  M, Caterson I. Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial. Clin Obes. 2014;4(2): 61-8. DOI: 10.1111/cob.12048.